Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 48:
49. The compound of claim 47, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C6-C10 aryl, wherein the C6-C10 aryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2d substituents:
each R2d is independently halogen, CN, C1-C6 alkyl, OR5, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, and 5- to 10-membered heteroaryl is optionally and independently substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is independently halogen, C1-C6 alkyl or OR8.